Orphazyme to convene creditors for meeting on company restructuring
Orphazyme’s creditors and management will face each other on April 7 after a run of bad news from the biotech company.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen
Biotech company Orphazyme’s has commenced in-court restructuring proceedings, a press release announces on Friday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Orphazyme gets requested observation status
For subscribers
Orphazyme seeks court protection during restructuring
For subscribers
